Buy this Article for $7.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Keywords

BRAF Inhibitors, (MAP) Kinase Pathway, MEK Inhibitors, Melanoma

 

Authors

  1. Smith, Vanessa
  2. Walton, Shernaz

Abstract

ABSTRACT: We discuss the recent breakthroughs in the treatment of metastatic malignant melanoma. New therapies, which target the mitogen-activated protein kinase pathway, such as BRAF inhibitors and MEK inhibitors, may provide hope for those with metastatic disease where, historically, treatment has not been successful.